Chamniansawat · Experimental & molecular medicine 2012 · In vitro cell culture experiment · n=?

A priming role of local estrogen on exogenous estrogen-mediated synaptic plasticity and neuroprotection.

Cited 39 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

In vitro bench research using an immortalized hippocampal cell line without human data.

PubMed 22510730 · doi:10.3858/emm.2012.44.6.046 · record verified 2026-08-29

What was done

The authors investigated the interaction between locally synthesized and exogenous 17β-estradiol (E2) using an in vitro hippocampal H19-7 cell model. Cells were treated with the aromatase inhibitor anastrozole to suppress local E2 production, combined with selective estrogen receptor agonists (ERα agonist PPT, ERβ agonist DPN), the PI3K pathway inhibitor wortmannin, hydrogen peroxide (H2O2) for oxidative challenge, and exogenous E2. Measured outcomes included ERα and ERβ expression, ERβ nuclear translocation, synaptic plasticity marker expression, cell viability, and Bcl-2 expression.

What was found

The abstract reports directional findings without quantitative metrics or effect sizes: - Anastrozole totally suppressed local hippocampal E2 and reduced ERβ expression without altering ERα expression. - PPT and DPN restored ERβ expression in anastrozole-treated cells. - Wortmannin blocked PPT-induced restoration of ERβ expression. - DPN induced basal ERβ translocation into the nucleus of anastrozole-treated cells. - Exogenous E2 increased synaptic plasticity marker expression in control cells, but failed to enhance synaptic plasticity in the anastrozole-treated group. - Exogenous E2 increased cell viability and Bcl-2 expression in H2O2-treated cells, but these protective effects were lost when anastrozole was co-administered.

Why it matters

This study provides mechanistic evidence that locally produced hippocampal estrogen acts as a necessary primer for exogenous estrogen to exert neuroprotective and synaptic plasticity-promoting effects. This could help clarify why responsiveness to hormone therapy might vary depending on endogenous tissue-level estrogen synthesis.

Limits

The study is entirely in vitro using an immortalized cell line (H19-7), limiting generalizability to intact central nervous system physiology. The abstract reports no numerical values, replicate counts, statistical significance levels, or specific identities of the tested synaptic plasticity markers.

Cited by